Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Biologics at Novartis
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation.
Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle.
[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
Acute disseminated encephalomyelitis--a prospective study of clinical profile and in-hospital outcome predictors.
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
Natalizumab in the treatment of rheumatoid arthritis in subjects receiving methotrexate
Embryonic stem cell lines derived from human blastocysts.
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life.
Prospective Examination of Anxiety and Depression Before and During Confirmed and Pseudoexacerbations in Patients With Multiple Sclerosis.
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2.
Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study.
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
Pages
« first
‹ previous
…
119
120
121
122
123
124
125
126
127
…
next ›
last »